HHealthcare Read More Novo Nordisk rebrands to ‘Novo’ under CEO Mike DoustdarSeptember 14, 2026 Novo Nordisk on Monday said it is rebranding its name to “Novo” and updating its corporate culture, as…
HHealthcare Read More This medical device stock looks like a gift for patient investorsSeptember 2, 2026 Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…
HHealthcare Read More Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug pushAugust 31, 2026 Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
HHealthcare Read More Wall Street analysts just called this healthcare stock a buy — here’s our takeAugust 19, 2026 Every weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET.…
HHealthcare Read More Novo Nordisk CEO defends lawsuit against Eli Lilly: ‘Competition has to be fair’August 13, 2026 Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…
HHealthcare Read More Lilly sues six firms over alleged illegal sales of obesity drug retatrutideAugust 12, 2026 Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
HHealthcare Read More Foundayo: Eli Lilly wins U.K. approval, challenging Wegovy weight-loss pillAugust 11, 2026 Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it…
HHealthcare Read More Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 marketAugust 6, 2026 The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of…
HHealthcare Read More We’re increasing our Eli Lilly price target after another beat-and-raise quarterAugust 6, 2026 Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…
HHealthcare Read More Eli Lilly (LLY) earnings Q2 2026August 5, 2026 Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook,…
HHealthcare Read More Novo Nordisk releases earnings and guidanceAugust 5, 2026 Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…
HHealthcare Read More FedEx is chasing the GLP-1 boom. Why healthcare logistics means big businessAugust 2, 2026 The boom in GLP-1 weight-loss drugs and other specialized medicines has created lucrative logistics opportunities in an industry…